Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

4.1K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

14.1K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of capsule endoscopy in patients with chronic and recurrent abdominal pain: Abbreviated running title: capsule endoscopy in abdominal pain.

Medical engineering & physics·2022
Same author

Experiment on the Properties of Soda Residue-Activated Ground Granulated Blast Furnace Slag Mortars with Different Activators.

Materials (Basel, Switzerland)·2022
Same author

Properties and Hydration Mechanism of Soda Residue-Activated Ground Granulated Blast Furnace Slag Cementitious Materials.

Materials (Basel, Switzerland)·2021
Same author

Inhibition of β-glucosidase overcomes gastric cancer chemoresistance through inducing lysosomal dysfunction.

Clinics and research in hepatology and gastroenterology·2020
Same author

Effect of Soda Residue Addition and Its Chemical Composition on Physical Properties and Hydration Products of Soda Residue-Activated Slag Cementitious Materials.

Materials (Basel, Switzerland)·2020
Same author

<i>UBE2D1</i> RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma.

Disease markers·2018

Related Experiment Video

Updated: Sep 22, 2025

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
10:11

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

23.2K

IPO7 promotes pancreatic cancer progression via regulating ERBB pathway.

Ming Li1, Dongqiang Xu2, Yijun Zhan2

  • 1Department of Gastroenterology, Renmin Hospital of Wuhan University, Hubei Province, China.

Clinics (Sao Paulo, Brazil)
|May 19, 2022
PubMed
Summary

Importin 7 (IPO7) drives pancreatic cancer progression by enhancing cell proliferation, migration, and invasion. This oncogenic factor up-regulates ERBB2, accelerating tumor growth and metastasis.

Keywords:
ERBB pathwayIPO7Pancreatic cancer

More Related Videos

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

538
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

930

Related Experiment Videos

Last Updated: Sep 22, 2025

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
10:11

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

23.2K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

538
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

930

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Importin 7 (IPO7) is a member of the Importin β family implicated in various human cancers.
  • Its specific role in pancreatic cancer (PC) pathogenesis and underlying mechanisms require investigation.

Purpose of the Study:

  • To elucidate the function of IPO7 in pancreatic cancer development.
  • To identify downstream pathways regulated by IPO7 in PC.

Main Methods:

  • Quantitative analysis of IPO7 expression in PC tissues and cells using IHC, qRT-PCR, and Western blotting.
  • In vitro assays (CCK-8, EdU, wound healing, Transwell, flow cytometry, TUNEL) to assess cell proliferation, migration, invasion, and apoptosis following IPO7 modulation.
  • Gene Set Enrichment Analysis (GSEA) and Western blotting to explore IPO7's molecular targets, including ERBB2.
  • In vivo studies using a xenograft mouse model to evaluate IPO7's tumorigenic potential.

Main Results:

  • IPO7 expression is significantly upregulated in pancreatic cancer tissues and cells.
  • IPO7 overexpression promotes PC cell proliferation, migration, and invasion while inhibiting apoptosis.
  • Knockdown of IPO7 reverses these effects, suppressing tumor growth and lung metastasis in vivo.
  • IPO7 upregulates ERBB2 expression, contributing to the malignant phenotype.

Conclusions:

  • IPO7 functions as an oncogenic factor in pancreatic cancer.
  • IPO7 accelerates PC progression by upregulating ERBB2 and modulating the ERBB pathway.